Cerebellum and dystonia: The story continues. Will the patients benefit from new discoveries?

被引:10
|
作者
Bares, Martin [1 ,2 ,3 ]
Filip, Pavel [1 ,2 ]
机构
[1] Masaryk Univ, Dept Neurol 1, Fac Med, Brno, Czech Republic
[2] St Annes Teaching Hosp, Brno, Czech Republic
[3] Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA
关键词
CERVICAL DYSTONIA; ADAPTATION;
D O I
10.1016/j.clinph.2017.10.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:282 / 283
页数:2
相关论文
共 50 条
  • [41] NORDIC LONGITUDINAL DATA FROM ELECTRONIC MEDICAL RECORDS AND FULL POPULATION NATIONAL REGISTERS: UNIQUE OPPORTUNITIES FOR NEW INSIGHTS IN BENEFIT OF DIABETES PATIENTS
    Lindh, A.
    Persson, F.
    Sobocki, P.
    Bodegard, J.
    Lindarck, N.
    VALUE IN HEALTH, 2015, 18 (07) : A726 - A726
  • [43] Clinical widened diagnostic criteria and prediction models identify "MODY-X" patients who should benefit from new specific genetic screening
    Leroy, C.
    Fajardy, I.
    Vaxillaire, M.
    Froguel, P.
    Fontaine, P.
    Vambergue, A.
    DIABETOLOGIA, 2013, 56 : S150 - S150
  • [44] Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review
    Gutierrez-Rojas, Luis
    Jose de la Gandara Martin, Jesus
    Garcia Buey, Luisa
    Uriz Otano, Juan I.
    Mena, Alvaro
    Roncero, Carlos
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (05): : 382 - 396
  • [45] Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy
    Pinto, Cathy Anne
    Tervonen, Tommi
    Marsh, Kevin
    Lambrelli, Dimitra
    Schultze, Anna
    Tershakovec, Andrew
    Hyacinthe, Johanna
    Prawitz, Thibaud
    Hammad, Tarek A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (04) : 443 - 451
  • [46] A single centre retrospective analysis on the ability to identify transplant-ineligible patients with Multiple Myeloma (MM) who are not likely to benefit from new standard therapies
    Offidani, Massimo
    More, Sonia
    Corvatta, Laura
    Manieri, Valentina Maria
    Olivieri, Attilio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S128 - S128
  • [47] IDENTIFYING TRANSPLANT-INELIGIBLE PATIENTS (NTE) WITH MULTIPLE MYELOMA (MM) WHO MAY NOT BENEFIT FROM NEW STANDARD THERAPIES: A RETROSPECTIVE ANALYSIS OF A SINGLE CENTRE
    More, S.
    Corvatta, L.
    Manieri, V. M.
    Olivieri, A.
    Offidani, M.
    HAEMATOLOGICA, 2021, 106 (10) : 91 - 92
  • [48] Usefulness of a new risk score to identify patients with non-ST-segment elevation acute coronary syndromes who benefit from an invasive treatment strategy
    Santos, JF
    Aguiar, CT
    Ferreira, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 223A - 223A
  • [49] 'BENEFIT' Pan-European Observational Study to Evaluate the Real-world Effectiveness of SB4 Transition from Originator Etanercept (ETN) in Patients with Rheumatoid Arthritis or Axial Spondyloarthritis: A Switch Success Story
    Selmi, Carlo
    Kruger, Klaus
    Cantagrel, Alain
    Hernandez, Abad
    Freudensprung, Ulrich
    Rezk, Mourad Farouk
    Addison, Janet
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [50] New size cut-off proposed by EAU Renal Cancer Working group better identifies patients who can benefit from local tumor ablation
    Piazza, P.
    Bianchi, L.
    Luzzago, S.
    Bandini, M.
    Mottaran, A.
    Amirhassankhani, S.
    Bernardino, D. C.
    Celia, A.
    Serra, C.
    Cappelli, A.
    Golfieri, R.
    Musi, G.
    Gallina, A.
    Liguori, G.
    Trombetta, C.
    De Cobelli, F.
    Mauri, G.
    Orsi, F.
    Capitanio, U.
    Schiavina, R.
    De Cobelli, O.
    Montorsi, F.
    Brunocilla, E.
    EUROPEAN UROLOGY, 2023, 83